Increased Expression of Adiponectin Receptor 2 in the Mononuclear Cells in Children With Prader-Willi Syndrome

Completed

• Conditions: Obesity; Prader-Willi Syndrome

• Registration Number: NCT00800852
• Lead Sponsor: Samsung Medical Center

Brief Summary

The inflammatory process is involved in the pathogenesis of obesity. Prader-Willi syndrome (PWS) is a genetic model of syndromic obesity. Adiponectin is an adipokine with potent anti-inflammatory properties, and its effect is mediated through adiponectin receptors 1 (adipoR1) and 2 (adipoR2).

Objective of this study is to compare the expression of adipoR1, adipoR2, and adiponectin in peripheral blood mononuclear cells (PBMCs) in PWS children and obese control and to correlate receptor expression with insulin sensitivity and obesity-related parameters.

Detailed Description

Not available

Study Timeline

• Status Verified: 2008-11
• Study First Submitted: 2008-11-30
• Study First Submitted QC: 2008-12-01
• Last Update Submitted: 2008-12-01
• Study First Posted: 2008-12-02
• Last Update Posted: 2008-12-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• children with Prader-willi syndrome
• children with simple obesity

Exclusion Criteria

• subjects with diabetes mellitus (fasting plasma glucose > 126 mg/dL with a 2-h oral glucose tolerance test value of >200 mg/dl)

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified